Group

p

C

P

First stage

IgA, µg/mL

30.85 ± 2.07

33.82 ± 2.11

0.35

IgG, µg/mL

−104.69 ± 9.76

−112.26 ± 8.67

0.58

IL-1β, ng/mL

17.82 ± 1.74

11.98 ± 2.14

0.08

TNF-α, ng/mL

3.33 ± 5.62

3.63 ± 2.67

0.96

IL-4, ng/L

47.93 ± 1.98

0.00 ± 0.79

<0.01

IL-6, ng/L

2.98 ± 0.53

2.51 ± 0.16

0.42

IFN-γ, ng/L

−280.13 ± 33.20

−224.76 ± 22.38

0.22

GH, µg/L

−1.08 ± 0.43

−3.61 ± 0.28

<0.01

LP, µg/L

−0.40 ± 0.18

1.48 ± 0.14

<0.01

Second stage

IgA, µg/mL

2.455 ± 1.23

0.70 ± 0.47

0.23

IgG, µg/mL

−1.89 ± 57.51

65.45 ± 9.68

0.29

IL-1β, ng/mL

9.46 ± 2.64

10.60 ± 2.85

0.78

TNF-α, ng/mL

9.09 ± 5.07

9.17 ± 3.15

0.99

IL-4, ng/L

−41.86 ± 1.29

−45.35 ± 4.54

0.49

IL-6, ng/L

7.31 ± 0.45

7.46 ± 0.08

0.76

IFN-γ, ng/L

153.00 ± 20.55

108.35 ± 28.19

0.25

GH, µg/L

−0.12 ± 0.17

0.71 ± 0.47

0.15

LP, µg/L

0.08 ± 0.34

0.90 ± 0.27

0.11